Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-003841
Filing Date
2020-03-17
Accepted
2020-03-17 17:46:13
Documents
1
Period of Report
2020-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3063
  Complete submission text file 0001179110-20-003841.txt   4423
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803
Business Address
Bazemore Todd (Reporting) CIK: 0001605767 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 20722289